Granted Type B Pre-NDA Meeting for Elamipretide as a Treatment for Barth Syndrome

Cookies are blocked. You have to allow cookies to start the session. (More)

01/06/2021 | 08:30 am EST

Stealth BioTherapeutics

Granted Type B Pre-NDA Meeting for Elamipretide as a Treatment for Barth Syndrome

First name*:

Last name*:

Company*:

Email*:

I have read the notice on the protection of my personal data and accept it.